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1. Introduction 
The selective modification of one alcohol group in a 
polyhydroxylated compound is an important issue for organic 
chemists since usually it requires time-consuming protection and 
deprotection steps that enhance costs and by-products lowering 
the final yields. In this sense, biocatalytic transformations have 
become standard procedures applied to the regioselective 
acylation of polyfunctionalised derivatives maximising the 
efficiency of these processes.
1
 Furthermore, in many cases the 
acylated derivatives obtained present better biological or 
availability properties than the parent substrates.
1,2 
This is also the case of chloramphenicol, (1R,2R)-2-
dichloroacetamido-1-p-nitrophenyl-1,3-propanediol (1, Chart 1),
3
 
a bacteriostatic antimicrobial which acts as an effective agent 
against a broad spectra of gram-positive and gram-negative 
bacteria. It was introduced for clinical treatment in human and 
animals around the mid 20th century, and its first indication was 
in the treatment of typhoid. Furthermore, its efficiency in the 
treatment of tetracycline-resistant cholera, staphylococcal brain 
abscesses, meningitis, influenza, pneumonia, and several 
infections has effectively been demonstrated over the years.
4
 
Unfortunately, it can also produce adverse effects such as aplastic 
anaemia, bone marrow suppression, childhood leukemia, and 
gray baby syndrome, so this compound requires medical 
prescription. For the administration of this drug there are 
currently several ways, for instance capsules, oily or liquid form, 
but the bitter taste of the pharmaceutical has led to the production 
of different alternatives such as chloramphenicol succinate or 
chloramphenicol palmitate (2a, Figure 1) esters by selective 
modification of the primary hydroxyl group. 
 
Figure 1. Structures of chloramphenicol (1) and chloramphenicol 
palmitate ester (2a). 
 
Originally, chloramphenicol was isolated from the bacterium 
Streptomyces venezulae,
5
 but the production of this drug and its 
derivatives have attracted very much attention by means of regio- 
or stereoselective chemical
6
 and enzymatic
7
 methods. Among all 
biocatalytic processes, the use of lipases presents many 
advantages in comparison with other synthetic transformations 
due to the mild reaction conditions and the high level of 
selectivity displayed by this type of catalysts. In this manner, 
Ottolina et al. reported the lipase-mediated regioselective 
esterification of chloramphenicol for the synthesis of several 
derivatives in anhydrous acetone exploring the influence of 
different trifluoroethyl esters. Chromobacterium viscosum lipase 
(CVL) or lipase G were the best biocatalytic agents, obtaining the 
corresponding esters after 24 to 72 hours of reaction at 45 ºC in 
moderate to excellent yields.
8
 Later, Lin and co-workers 
demonstrated the versatility of hydrolases such as Lipozyme or 
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the protease from Bactillus subtilis in the synthesis of 
chloramphenicol vinyl esters.
9 
Herein we develop the synthesis of a wide set of 
chloramphenicol esters by using complementary synthetic 
approaches such as acylation and hydrolysis processes. We have 
especially focused on the optimisation of the reaction conditions 
including the scaling-up and the enzyme recycling outcome. 
2. Results and Discussion 
First of all, different commercially available lipases were 
tested
10
 in order to find the highest activity in the esterification of 
chloramphenicol with a half-size chain activated ester such as 
vinyl decanoate (3b). From previous studies developed in our 
research group, 1,4-dioxane was selected as suitable solvent 
using 5 equivalents of the acyl donor (Scheme 1, Table 1). 
 
Scheme 1 Lipase-mediated esterification of chloramphenicol 
(1) using vinyl esters 3a-f in organic solvents. 
 
After 48 hours at 30 ºC and 250 rpm, Candida antarctica 
lipase A (CAL-A, entry 1) gave low conversion and poor 
selectivity, affording the formation of the 3’-acylated compound 
(2b) and the 1’,3’-diacylated product (4b). Candida antarctica 
lipase B (CAL-B) catalysed the acylation reaction with good 
selectivity and reaction rate, yielding 72% of the desired 3’-
monoacylated derivative (entry 2). Meanwhile, as shown in 
entries 3 and 4, two different preparations of Pseudomonas 
cepacia lipases from Amano (PSL-C Amano, also known as 
Burkholderia cepacia lipase) and type I from Aldrich (PSL-C I), 
produced with complete selectivity the monoester 2b in 87% and 
94% conversion respectively as the sole product. These 
achievements were ideal starting points for further optimisation 
of the reaction conditions. 
Table 1 Lipase-mediated reaction of 1 with 5 equiv. of vinyl 
decanoate (3b) in 1,4-dioxane at 30 ºC after 48 h. 
Entry Enzyme 2b (%)a 4b (%)a 
1 CAL-A 22 11 
2 CAL-B 72 5 
3 PSL-C Amano 87  
4 PSL-C I 94  
a Percentage of compounds determined by HPLC. 
Due to the results obtained for these two biocatalysts, a search 
for a suitable solvent was carried out taking CAL-B and PSL as 
catalysts applied to the regioselective esterification of 
chloramphenicol. Reactions were performed for 24 and 48 hours 
(Table 2). The influence of tetrahydrofuran (THF), acetonitrile 
(MeCN), and tert-butyl methyl ether (TBME) was initially 
examined with CAL-B (entries 1-6), where the highest 
conversions were with MeCN (entry 4), which allowed the 
formation of 2b in 80% yield after 48 hours. It should be noted 
that the diacylated compound 4b was not detected in any case. 
Different results were attained when using PSL as biocatalyst 
(entries 7-18). None of the three solvents improved the high 
performance obtained in 1,4-dioxane (87 and 94% in entries 3 
and 4 of Table 1, respectively) although with acetonitrile higher 
conversions than THF and TBME were achieved. 
Table 2 Lipase-mediated reaction of 1 with 5 equiv. of vinyl 
decanoate (3b) in different organic solvents at 30 ºC. 
Entry Enzyme Solvent t (h) 2b (%)a 
1 CAL-B THF 24 31 
2 CAL-B THF 48 37 
3 CAL-B MeCN 24 74 
4 CAL-B MeCN 48 80 
5 CAL-B TBME 24 27 
6 CAL-B TBME 48 29 
7 PSL-C Amano THF 24 15 
8 PSL-C Amano THF 48 21 
9 PSL-C Amano MeCN 24 51 
10 PSL-C Amano MeCN 48 62 
11 PSL-C Amano TBME 24 42 
12 PSL-C Amano TBME 48 51 
13 PSL-C I THF 24 12 
14 PSL-C I THF 48 17 
15 PSL-C I MeCN 24 33 
16 PSL-C I MeCN 48 50 
17 PSL-C I TBME 24 38 
18 PSL-C I TBME 48 43 
a Percentage of compounds determined by HPLC. 
The effect of the temperature was analysed when employing 
the best conditions previously found: a) CAL-B and MeCN; or b) 
PSL-C I and 1,4-dioxane (Table 3).
11
 Surprisingly, CAL-B led to 
a higher conversion into 2b at 20 ºC rather than at 30 ºC (entries 
1 and 2), although this enzyme usually presents an optimum 
temperature between 30-40 ºC.
12
 When using PSL-C I, a 
remarkable decrease of the conversion occurred when going from 
30 to 40 ºC (entries 4 and 5), maybe caused by deactivation of 
the biocatalyst, meanwhile the reaction at 20 ºC (entry 3) led to a 
similar value than the one obtained at 40 ºC. 
Table 3 Temperature effect in the lipase-catalysed acylation 
of 1 with 5 equiv. of vinyl decanoate (3b) after 48 h. 
Entry Enzyme Solvent T (ºC) 2b (%)a 
1 CAL-B MeCN 20 94 
2 CAL-B MeCN 30 80 
3 PSL-C I 1,4-Dioxane 20 61 
4 PSL-C I 1,4-Dioxane 30 94 
5 PSL-C I 1,4-Dioxane 40 58 
a Percentage of compounds determined by HPLC. 
After optimisation of the experimental conditions for the 
acylation reaction, we explored the possibilities to 
regioselectively produce several chloramphenicol ester 
derivatives of different length chain using CAL-B or both 
preparations of PSL-C as biocatalysts in MeCN or 1,4-dioxane as 
solvent, respectively. The best results have been summarised in 
Table 4. Chloramphenicol palmitate ester (2a) was selected as the 
 3 
first candidate due to its therapeutical uses
13
 and results were in 
accordance with the ones obtained when using vinyl decanoate as 
acyl donor. Both CAL-B and PSL-C I led to nearly complete 
conversions after 24 h of reaction (entries 1 and 2). 
Next, vinyl laurate (3c) was reacted with 1 also observing an 
excellent reactivity (entries 3 and 4), especially in the case of 
CAL-B which led to quantitative conversion of the monoester 2c. 
This trend was also observed when the chain length of the vinyl 
ester decreased, obtaining excellent results when vinyl 
propanoate (3d) was employed as acyl donor with all the 
biocatalysts tested (entries 5-7). Surprisingly, longer reactions 
times were needed to reach high conversion values using vinyl 
acetate (3e, entries 8 and 9). Vinyl benzoate (3f) led to the lowest 
conversion values (entries 10 and 11) due to the poorer reactivity 
of this acyl donor. These results present lipases as ideal 
catalysts for the regioselective acylation of chloramphenicol, 
showing an excellent selectivity towards the acylation of the 
primary alcohol. It is important to remark that in no case was the 
secondary hydroxyl group acylated to form the corresponding 1’-
monoester or 1’,3’-diester derivatives, even after longer reaction 
times (data not shown). 
From a preparative point of view, both higher substrate 
concentrations and recycling of the catalyst lead to more 
economical and green processes.
14
 Therefore, after testing the 
solubility of all products involved in these processes, the 
reactions to achieve 2a-f were carried out at a higher 
concentration of chloramphenicol (0.15 M), as summarized in 
Table 5. 
Table 4 Enzymatic acylation of 1 with 5 equiv. of the vinyl ester 3a,c-f at different temperatures in a 15 mM 
substrate concentration. 
Entry Enzyme T (ºC) Solvent Final product t (h) conv (%)a 
1 CAL-B 20 MeCN 2a 24 >99 
2 PSL-C I 30 1,4-Dioxane 2a 24 95 
3 CAL-B 20 MeCN 2c 24 >99 
4 PSL-C I 30 1,4-Dioxane 2c 24 91 
5 CAL-B 20 MeCN 2d 24 >99 
6 PSL-C Amano 30 1,4-Dioxane 2d 24 99 
7 PSL-C I 30 1,4-Dioxane 2d 24 95 
8 CAL-B 20 MeCN 2e 40 >99 
9 PSL-C Amano 30 1,4-Dioxane 2e 40 97 
10 CAL-B 20 MeCN 2f 40 4 
11 PSL-C Amano 30 1,4-Dioxane 2f 40 17 
a Percentage of compounds determined by HPLC. 
Table 5 Lipase-mediated reaction of 1 with 5 equiv. of the vinyl ester 3a-f at different temperatures and 250 rpm at 0.15 M 
substrate concentration. 
Entry Enzyme T (ºC) Solvent Final product t (h) conv (%)a Isolated yield (%)b 
1 CAL-B 20 MeCN 2a 3 >99 91 
2 PSL-C I 30 1,4-Dioxane 2a 3 >99 75 
3 PSL-C Amano 30 1,4-Dioxane 2a 48 79 78 
4 CAL-B 20 MeCN 2b 3 >99 92 
5 PSL-C I 30 1,4-Dioxane 2b 4 >99 84 
6 PSL-C Amano 30 1,4-Dioxane 2b 22 >99 91 
7 CAL-B 20 MeCN 2c 4 >99 91 
8 PSL-C I 30 1,4-Dioxane 2c 7 >99 88 
9 PSL-C Amano 30 1,4-Dioxane 2c 10 >99 88 
10 CAL-B 20 MeCN 2d 3 >99 89 
11 PSL-C I 30 1,4-Dioxane 2d 6 98 90 
12 PSL-C Amano 30 1,4-Dioxane 2d 9 >99 82 
13 CAL-B 20 MeCN 2e 3 >99 90 
14 PSL-C I 30 1,4-Dioxane 2e 6 99 90 
15 PSL-C Amano 30 1,4-Dioxane 2e 9 98 79 
16 CAL-B 20 MeCN 2f 48 31 25 
17 PSL-C I 30 1,4-Dioxane 2f 48 53 45 
18 PSL-C Amano 30 1,4-Dioxane 2f 48 13 8 
a Percentage of compounds determined by HPLC. 
b Isolated yields after purification by flash chromatography. 
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In all cases the reaction times diminished in comparison with 
the more diluted one (see Table 4), finding that for CAL-B only 3 
or 4 h were enough to afford total conversions into the 
corresponding monoesters 2a-e. Among all the enzymatic 
processes carried out with PSL, PSL-C I showed better reaction 
rates than PSL-C Amano. Finally, the biotransformations with 
vinyl benzoate (entries 16-18) led also to higher conversions at 
150 mM concentration rather than 15 mM, obtaining 45% 
isolated yield of monoester 2f with PSL-C I (entry 17). 
The next step was to study the recycling the enzyme by 
performing the acylation at 0.15 M concentration of 1 and vinyl 
palmitate with CAL-B in MeCN at 20 ºC. The biocatalyst 
performed the regioselective synthesis of 2a with total 
conversion after 3 h during 10 cycles of reutilisation. 
After having found excellent conversion in the biocatalysed 
regioselective acylation of diol 1, we set up a preparative 
experiment at 1 g-scale. For that, the biocatalytic processes to 
obtain derivatives 2a-e were performed using the best conditions 
previously found for the acylation at 0.15 M concentration of 1: 
CAL-B as biocatalyst, 5 equiv. of the corresponding ester and 
MeCN as solvent at 20 ºC. All the reactions proceeded until 
complete conversion to isolate 2a-b,d-e in 3 hours, requiring 4 
hours for the laurate ester 2c. Additionally, the palmitate 
derivative 2a was obtained in 98% conversion when the reaction 
was repeated at 0.25 M concentration of chloramphenicol. Further 
increase of substrate concentration led to solubility problems. 
Previous experiments have demonstrated that the acylated 
derivatives of chloramphenicol at the primary alcohol can be 
obtained with high yields, but we were also interested in the 
obtaining of analogues acylated at the more hindered secondary 
position. The chemical modification of a secondary alcohol in the 
presence of a primary one is a complicated feature which has 
scarcely been observed.
15
 Herein, taking advantage of the 
chemical complementarity shown by lipases in stereo- and 
regioselective processes,
16
 we focused on the preparation of 
monoesters 5a-e by firstly synthesising the diacylated derivatives 
4a-e, and later performing the regioselective lipase-catalysed 
hydrolysis at the primary position (Scheme 2). 
 
Scheme 2 Lipase-catalysed hydrolysis of diacylated 
chloramphenicol derivatives 4a-e in aqueous media. 
 
Enzymatic hydrolyses were initially performed with the 
diacetylated compound 4e by employing a mixture of phosphate 
buffer 100 mM pH 7.0 and an organic co-solvent (80:20 v v
-1
) 
such as MeCN, 1,4-dioxane or THF with the previous lipases, but 
only CAL-B showed activity (Table 6). Using this biocatalyst the 
3’-acylated derivative 2e was not observed in any case and the 
desired product 5e was mainly achieved in MeCN at 20ºC with 
high conversion (78%), giving substrate 4e and chloramphenicol 
1 as minor compounds (entry 3). Percentage of MeCN in the 
reaction medium (5-80%) and the pH of the reaction (range 5.5-
8.5) were also studied (see Supplementary material for more 
information), but no further improvement of the conversion 
values was achieved. 
Table 6 Lipase-mediated hydrolysis of 4e with CAL-B in a 
buffer/organic solvent system (80/20 v v
-1
) at different 
temperatures and 250 rpm at 0.15 M concentration (t= 24 h). 
Entry T (ºC) Solvent 1 (%)a 4e (%)a 5e (%)a 
1 20 1,4-Dioxane 23 63 14 
2 30 1,4-Dioxane 18 73 9 
3 20 MeCN 14 8 78 
4 30 MeCN 8 18 74 
5 20 THF 12 21 67 
6 30 THF 16 54 30 
a Percentage of compounds determined by HPLC and 1H-NMR. 
The hydrolyses of diacylated derivatives 4a-d were then 
carried out under the optimal conditions depicted in entry 3 of 
Table 6, observing a correlation between the chain length of the 
ester moiety and the enzymatic conversion (Figure 2). Thus, 
when longer ester moieties were employed, lower conversions 
were reached. While the dipropionate compound 4d afforded 
74% of 5d,
17
 didecanoate 4b provided only a 10% of 5b, 
dilaurate 4c a 4% of 5c, and dipalmitate 4a did not react. This 
effect can be explained because bulkier diacylated products could 
not correctly fit in the active site of the enzyme. 
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Figure 2 Effect of the chain length in the CAL-B-catalysed hydrolysis of 
diacylated chloramphenicol derivatives. 
 
3. Conclusions 
In summary, we have successfully demonstrated the versatility 
of lipases, especially CAL-B, applied to the regioselective 
production of chloramphenicol esters, acylating or hydrolysing 
the primary position in short reaction times. Industrial application 
of the transesterification reaction has been considered showing 
the possibility to carry out the experiments at high substrate 
concentrations (0.25 M) and recycling the enzyme for a large 
number of cycles (up to 10), thus obtaining interesting 
compounds such as the palmitate derivative with excellent yields. 
Furthermore, monoacylated compounds on the secondary alcohol 
group, difficult to achieve by conventional methodologies, were 
obtained with good to moderate yields through biocatalysed 
regioselective hydrolytic processes. 
4. Experimental Section 
4.1. General 
Immobilised Candida antarctica lipase type B (CAL-B, 
Novozym 435, 7300 PLU/g) was a gift from Novo Nordisk Co. 
Immobilised Pseudomonas cepacia lipases PSL-C Amano (1019 
 5 
U/g) and PSL-C I (1638 U/g) were acquired from Amano 
Pharmaceutical Co. and Sigma-Aldrich respectively. Candida 
antarctica lipase A (CAL-A) was purchased from Codexis (2.6 
U/mg of solid). All other reagents were purchased from different 
commercial sources and used without further purification. 
Solvents were distilled over an adequate desiccant under 
nitrogen. Flash chromatographies were performed using silica 
gel 60 (230-240 mesh). 
4.2. General procedure for the esterification reaction of (–)-
chloramphenicol at 0.25 M substrate concentration using 
vinyl palmitate 
To a suspension of (–)-chloramphenicol (1, 1 g, 3.1 mmol) 
and CAL-B (1 g) in dry MeCN (12.5 mL) under nitrogen 
atmosphere, vinyl palmitate (3a, 4.26 g, 15.0 mmol) was added, 
and the reaction was shaken at 20 ºC and 250 rpm. Aliquots were 
regularly analysed by HPLC and the reaction was stopped after 
complete consumption of the starting material after 1 h. Finally 
the enzyme was filtered off and washed with EtOAc (3 × 10 mL). 
The solvent was evaporated under reduced pressure. The reaction 
crude was purified by flash chromatography on silica gel (30% 
EtOAc/hexane) affording the corresponding ester 2a (87% 
isolated yield). Characterizations of monoester 2a and all novel 
compounds are given in the supporting information file. 
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